It has been shown that TP53 mutation, or loss of normal-p53 often evokes mesenchymal phenotypes of breast cancer cells and lung cancer cells, to be often coupled with the acquisition of cancer stem cell-like cell properties8,9. This evidence concerns the gene TP53 and cancer.